跳轉至內容
Merck
全部照片(1)

文件

5.00936

SAFC

维生素 D₃（胆钙化醇）晶体（1 g = 40 Mio.I.U.）

EMPROVE® ESSENTIAL, Ph. Eur., BP, USP

製藥生產

同義詞:

Vitamin D₃ (cholecalciferol) cryst. (1 g = 40 Mio.I.U.), Colecalciferol, Cholecalciferol

登入查看組織和合約定價
全部照片(1)

About This Item

CAS號碼:
67-97-0
分子量：:
384.64
MDL號碼:
MFCD00078131
分類程式碼代碼:
12352401
酶委員會索引編號:
200-673-2

agency

BP
Ph. Eur.
USP

品質等級

500

產品線

EMPROVE® ESSENTIAL

形狀

solid

mp

82-87 °C

溶解度

<0.1 g/L

應用

liquid formulation
pharmaceutical

儲存溫度

2-8°C

InChI

1S/C27H44O/c1-19(2)8-6-9-21(4)25-15-16-26-22(10-7-17-27(25,26)5)12-13-23-18-24(28)14-11-20(23)3/h12-13,19,21,24-26,28H,3,6-11,14-18H2,1-2,4-5H3/b22-12+,23-13+/t21-,24+,25-,26+,27-/m1/s1

InChI 密鑰

QYSXJUFSXHHAJI-FVUVGDFOSA-N

相關類別

一般說明

We offer a range of high quality critical raw materials, solvents and reagents plus the documentation and expertise to meet stringent regulatory requirements. In addition to our comprehensive portfolio, we also offer custom manufacturing services to meet your exact needs. As part of our Emprove® Program, our raw materials are offered with extensive documentation facilitating compliance of your pharma and biopharma product, full supply chain transparency and risk mitigation. Our SAFC® portfolio of high-quality products for biopharmaceutical and pharmaceutical formulation and production withstands strict quality control procedures and is produced according to applicable cGMP guidelines.

應用

Vitamin D3 is used in clinical nutrition for treatment of vitamin D3 deficiency and as skincare agent. Vitamin D3 Emprove® Essential is suitable for pharmaceutical applications.

法律資訊

Emprove is a registered trademark of Merck KGaA, Darmstadt, Germany
SAFC is a registered trademark of Merck KGaA, Darmstadt, Germany

象形圖

Skull and crossbonesHealth hazard
GHS06,GHS08

訊號詞

Danger

危險分類

Acute Tox. 2 Dermal - Acute Tox. 2 Inhalation - Acute Tox. 2 Oral - STOT RE 1 Oral

儲存類別代碼

6.1A - Combustible acute toxic Cat. 1 and 2 / very toxic hazardous materials

水污染物質分類（WGK）

WGK 2

閃點（°F）

Not applicable

閃點（°C）

Not applicable

分析證明 (COA)

輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號，寫有 ‘Lot’或‘Batch’.。

已經擁有該產品？

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

文章

Strategies for the Development of Safe and Effective Pediatric Formulations

Medicine for children poses unique formulation challenges compared to adults. Consider developmental physiology and age specifics when designing pharmaceuticals. Quality issues can severely impact patient safety. Therefore, excipient quality, supplier selection, and supply chain security are crucial, particularly for pediatric formulations.

安全有效的兒科製劑開發策略

與成人相比，兒童用藥面臨獨特的配方挑戰。在設計藥品時，請考慮兒童的發育生理和年齡特徵。品質問題會嚴重影響病患安全。因此，輔料品質、供應商選擇和供應鏈安全是至關重要的，特別是對於兒科配方。

相關內容

Pediatric Formulations

Developing formulations specifically for infants and children is increasingly important. To help you master these challenges effectively, we offer an extensive portfolio of well-established high-quality excipients and APIs for pediatric pharmaceutical formulations that are proven in practice.

我們的科學家團隊在所有研究領域都有豐富的經驗，包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務